Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4260 | CNTX Context Therapeutics Inc. - Common Stock | 0.64 USD | -8.57% | +8.47% | -61.90% | -1.54% | 58.80 M USD | ||
| 4276 | BOLD Boundless Bio, Inc. - Common Stock | 2.45 USD | -2.00% | -0.81% | +68.97% | +111.21% | 55.04 M USD | ||
| 4288 | INKT MiNK Therapeutics, Inc. - Common Stock | 10.87 USD | +0.74% | -6.05% | -6.21% | -1.18% | 54.15 M USD | ||
| 4295 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.21 USD | -1.07% | -0.86% | +20.87% | +1179.17% | 53.26 M USD | ||
| 4299 | TIL Instil Bio, Inc. - Common Stock | 7.76 USD | +0.13% | +0.91% | -4.79% | -60.18% | 52.63 M USD | ||
| 4309 | ABVC ABVC BioPharma, Inc. - Common Stock | 2.01 USD | -0.50% | +18.24% | +45.65% | -57.68% | 52.26 M USD | ||
| 4330 | TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.07 USD | 0.00% | -7.59% | +0.49% | -22.47% | 50.55 M USD | ||
| 4332 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.30 USD | -1.52% | +7.44% | +0.78% | -9.72% | 48.94 M USD | ||
| 4340 | MREO Mereo BioPharma Group plc - American Depositary Shares | 0.31 USD | -6.06% | -3.13% | +6.90% | -89.05% | 49.48 M USD | ||
| 4365 | INMB INmune Bio Inc. - Common stock | 1.70 USD | -2.30% | +1.19% | +34.92% | -26.09% | 45.19 M USD | ||
| 4367 | PDSB PDS Biotechnology Corporation - Common Stock | 0.80 USD | -4.76% | -9.09% | -20.79% | -37.01% | 44.65 M USD | ||
| 4374 | VERU Veru Inc. - Common Stock | 2.64 USD | -8.33% | -18.27% | -12.87% | +10.46% | 42.37 M USD | ||
| 4385 | HYPD Hyperion DeFi, Inc. - Common Stock | 2.84 USD | -0.70% | -9.84% | -2.07% | -77.06% | 43.05 M USD | ||
| 4400 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.43 USD | -3.19% | +6.58% | +3.40% | -38.94% | 39.55 M USD | ||
| 4405 | APLM Apollomics Inc. - Class A Ordinary Shares | 18.58 USD | -1.85% | -8.47% | +32.05% | +198.23% | 40.80 M USD | ||
| 4408 | RNXT RenovoRx, Inc. - Common Stock | 0.90 USD | -3.23% | -8.16% | +1.12% | -30.77% | 40.59 M USD | ||
| 4409 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.50 USD | +6.73% | +17.54% | +28.71% | -33.61% | 40.22 M USD | ||
| 4414 | GOSS Gossamer Bio, Inc. - Common Stock | 0.17 USD | -5.56% | 0.00% | 0.00% | -86.61% | 39.90 M USD | ||
| 4426 | ESLA Estrella Immunopharma, Inc. - Common Stock | 0.90 USD | -1.10% | -6.25% | -20.35% | +4.65% | 38.73 M USD | ||
| 4429 | LTRN Lantern Pharma Inc. - Common Stock | 3.11 USD | -12.89% | -21.86% | -17.94% | -25.78% | 35.16 M USD |
Nouvelles Biotechnology Stocks
Seres Therapeutics publie des données préliminaires sur les complications de la thérapie contre le cancer | Benzinga France
TD Cowen réitère son avis d’achat sur Prime Medicine après une victoire en arbitrage
BofA maintient sa recommandation sur Beam Therapeutics après la décision arbitrale
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |